- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06240910
Effects of Aerobic Training and Neurodynamics to Prevent Fall and Improve Balance in Patients With Diabetic Neuropathy
January 28, 2024 updated by: Riphah International University
Diabetes is a group of metabolic diseases, characterized by hyperglycemia resulting from defects in insulin secretion, actionor both.
The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of differentorgans, especially the eyes, kidneys, nerves, heart, and blood vessels.
In long standing cases of both diabetes type 1 and 2, about 60 % individuals had diabetic neuropathy.
Patients suffering from diabetes are more prone to fall, possibly due to balance issues and sensory ataxia.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study will be a Randomized controlled trial.
Participants who have DM2 for past 7 years and who score >2/13 on Michigan neuropathy screening instrument questionnaire with at least 2 DPN symptoms will be screened for this study.
Participants with any fracture in lower limb , complete loss of foot perception, comorbidities, using assistive devices and already involved in structured physiotherapy interventional program will be excluded from this randomized controlled trial study.
Participants will be selected with non-probability consecutive sampling and will be randomly allocated using computer generated randomizer in two groups i.e., experimental group and control group.
Balance and risk of fall will be assessed through Berg Balance scale, functional reach test , Romberg test and morse fall scale before and after giving interventions.
Treatment session will be given 3 days a week for 6 weeks.
Participants in control group will be given neurodynamics for sciatic nerve ( the total duration of interventions will be approximately 10 minutes a day for 3 days in a week for 6 weeks.
Experimental group will be given aerobic exercise interventions (involving warm-up by stretching and flexibility exercisesfor 5 minutes, treadmill walking and stationary bicycle training with 6 minutes a day for 3 days in a week for 6 weeks) along with neural mobilization for sciatic nerve ( 10 minutes a day for 3 days in a week for 6 weeks), so the total duration of interventions for experimental group will be 40-60 minutes a day for 3 days in a week for 6 weeks.
Given the high prevalence and substantial impact of diabetic neuropathy on balance and fall risk, it is imperative to explore effective interventions (aerobic exercise + neurodynamics) for managing these impairments.
Individuals may experience improved proprioception, enhanced muscle coordination, and optimized neural tissue mobility, leading to reduced fall risk and improved functional independence.
Data will be analyze using SPSS 23.
Study Type
Interventional
Enrollment (Estimated)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Muhammad Aqeel, MSPT(NM)
- Phone Number: 03037862835
- Email: ilyassaqeel@gmail.com
Study Contact Backup
- Name: Muhammad Usman, MSPT(NM)
- Phone Number: 03123381314
- Email: usmanikram993@gmail.com
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 5433
- Recruiting
- Ripha International University
-
Contact:
- Asrar Yousaf
- Phone Number: 030040995505
- Email: asrar.yousaf@riphah.edu.pk
-
Principal Investigator:
- Asrar Yousaf
-
Contact:
- Muhammad Aqeel, MSPT(NM)
- Phone Number: 03037862835
- Email: ilyassaqeel@gmail.com
-
Sub-Investigator:
- Doctor Wajiha
-
Lahore, Punjab, Pakistan, 5433
- Recruiting
- Riphah International University
-
Contact:
- Muhammad Usman, MSPT(NM)
- Phone Number: 03123381314
- Email: usmanikram993@gmai.com
-
Contact:
- Muhammad Asrar Yousaf, MSPT(NM)
- Phone Number: 03004099505
- Email: asrar.yousaf@riphah.edu.pk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Age ranged between 45-67 years.
- Both male and female genders
- DM for the past 7 years.
- Scored >2/13 on Michigan neuropathy screening instrument (MNSI) questionnaire including at least two DPN symptoms.
Exclusion Criteria:
fracture(s) in the lower limb.
- Any participant who suffered from foot ulcers.
- Unstable heart disease, co- Morbid conditions limiting exercise
- inability of subjects to understand and/or co-operate during quantitative sensory testing or manual/nerve mobility testing and/or treatment.
- Any level of physical activity i.e 150 minutes/week
- Receiving any structured supervised physiotherapy interventions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Neurodynamics
Neuro dynamics involving Stretching and gliding of the Sciatic nerve (performing each exercise for 30 s at a slow and comfortable pace of 1 repetition per ~3-4 s.
The participants rested for 60 s between each exercise.
The total duration of the interventions was approximately 10 min.).The whole treatment session on a single day will be of 40-60 minutes of duration (involving both aerobic exercise + neurodynamics) 3. times a week for 6 weeks according to the American diabetes association, accumulating a minimum of 150 minutes/week.
|
Neuro dynamics involving Stretching and gliding of the Sciatic nerve (performing each exercise for 30 s at a slow and comfortable pace of 1 repetition per ~3-4 s.
The participants rested for 60 s between each exercise.
|
|
Experimental: Aerobic training
Aerobic exercise will involve warm-up by stretching and flexibility exercises for 5 minutes, Treadmill walking for 6 minutes, and Stationary bicycle for 6 minutes
|
Aerobic exercise will involve warm-up by stretching and flexibility exercises for 5 minutes, Treadmill walking for 6 minutes, and Stationary bicycle for 6 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berge balance scale
Time Frame: 6 weeks
|
The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional reach test
Time Frame: 6 weeks
|
Functional Reach Test (FRT) is a clinical outcome measure and assessment tool for ascertaining dynamic balance in one simple task.
|
6 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Morse scale
Time Frame: 6 weeks
|
This scale was published by Morse in 1989 and consists of six criteria for assessing the risk of falls: history of falling, secondary diagnosis, ambulatory aid, intravenous therapy/heparin lock, gait, and mental status.
|
6 weeks
|
|
Romberg test
Time Frame: 6 weeks
|
The Romberg test is a test that measures a persons sense of balance.
Specifically, the test assesses the function of the dorsal column of the spinal cord (the dorsal column is responsible for proprioception).
|
6 weeks
|
|
Michigan neuropathy screening instrument questionnaire
Time Frame: 6 weeks
|
The Michigan Neuropathy Screening Instrument (MNSI) is a valid screening tool for DN(19). The maximum score of the foot examination is 8 points and a score of equal to or greater than 2 is positive for DPN. |
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Muhammad Asrar Yousaf, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 17, 2023
Primary Completion (Estimated)
February 12, 2024
Study Completion (Estimated)
February 12, 2024
Study Registration Dates
First Submitted
January 28, 2024
First Submitted That Met QC Criteria
January 28, 2024
First Posted (Estimated)
February 5, 2024
Study Record Updates
Last Update Posted (Estimated)
February 5, 2024
Last Update Submitted That Met QC Criteria
January 28, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR&AHS/23/0236
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Neuropathies
-
Azienda di Servizi alla Persona di PaviaNot yet recruitingDiabetic Neuropathies, Painful | Neuropathic Pain Management | Palmitoylethanolamide
-
Carilion ClinicRecruitingDiabetic Foot | Diabetic Peripheral Neuropathy | Diabetic Neuropathies, PainfulUnited States
-
AstraZenecaCompletedDiabetic Neuropathy, Painful; Diabetic NeuropathiesUnited States
-
Maastricht University Medical CenterCompletedPainful Diabetic Neuropathy | Diabetic Neuropathies, Painful | Neuralgia, DiabeticNetherlands
-
WinSanTor, IncCompletedPeripheral Neuropathy | Painful Diabetic Neuropathy | Diabetic Neuropathies, PainfulCanada
-
Diskapi Teaching and Research HospitalCompletedDiabetic Neuropathy Peripheral | Diabetic Neuropathies, PainfulTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalNot yet recruiting
-
Riphah International UniversityNot yet recruiting
-
Helwan UniversityCompletedDiabetic PolyneuropathyEgypt
-
Services Hospital, LahoreServices Institute of Medical Sciences, PakistanCompleted
Clinical Trials on Neurodynamics
-
Yeditepe UniversityCompletedHamstring Tightness | Hamstring Injury PreventionTurkey
-
University of SharjahCompletedPhysical and Rehabilitation MedicineUnited Arab Emirates
-
Aveiro UniversityCompletedChronic Pain | Older Adults | Chronic Musculoskeletal Pain | Chronic Musculoskeletal DiseasePortugal
-
Lama Saad El-Din MahmoudCompletedFemoral Neuropathy in Haemophilic PatientsEgypt
-
National Yang Ming UniversityCompletedStroke | Chronic Stroke | Spasticity Post StrokeTaiwan
-
University of SevilleInstituto de Biomedicina (IBiS) de SevillaCompleted
-
University GhentCompletedRange of Motion | Hamstring Injury | Neurodynamics
-
Universidad Católica de ÁvilaCompleted
-
Universidad Europea de MadridCompletedCervicobrachial NeuralgiaVenezuela
-
Universidad Europea de MadridCompleted